Early and intermediate age-related macular degeneration: update and clinical review

QR Code

Early and intermediate age-related macular degeneration: update and clinical review

Alfredo García-Layana,1–3 Francisco Cabrera-López,4,5 José García-Arumí,6–8 Lluís Arias-Barquet,9,10 José M Ruiz-Moreno3,11,12 1Department of Ophthalmology, Clínica Universidad de Navarra, Pa...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	García-Layana A, Cabrera-López F, García-Arumí J, Arias-Barquet L, Ruiz-Moreno JM
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2017
Sujets:	Age-related macular degeneration early AMD intermediate AMD risk factors classification prevention nutritional supplementation. Geriatrics RC952-954.6
Accès en ligne:	https://doaj.org/article/d731c77c78f34c34861df8da6f0fe0b4
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Visual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosis
par: Canan H, et autres
Publié: (2014)

Differential Circulating MicroRNA Expression in Age-Related Macular Degeneration
par: Hanan ElShelmani, et autres
Publié: (2021)

The emotional and physical impact of wet age-related macular degeneration: findings from the wAMD Patient and Caregiver Survey
par: Varano M, et autres
Publié: (2016)

Clinical observations on the use of new anti-VEGF drug, conbercept, in age-related macular degeneration therapy: a meta-analysis
par: Cui C, et autres
Publié: (2017)

Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group
par: Amoaku W, et autres
Publié: (2018)

Cost-Effectiveness of Conbercept vs. Ranibizumab for Age-Related Macular Degeneration, Diabetic Macular Edema, and Pathological Myopia: Population-Based Cohort Study and Markov Model
par: Zhuang Cui, et autres
Publié: (2021)

Choriocapillaris Vascular Density Changes: Healthy vs. Advanced Exudative Age-Related Macular Degeneration Previously Treated with Multiple Anti-VEGF Intravitreal Injections
par: Maria Cristina Savastano, et autres
Publié: (2021)

Neovascular age-related macular degeneration: intraocular inflammatory cytokines in the poor responder to ranibizumab treatment
par: Pongsachareonnont P, et autres
Publié: (2018)

Twelve-week dosing with Aflibercept in the treatment of neovascular age-related macular degeneration
par: Garweg JG
Publié: (2019)

Medication Trends for Age-Related Macular Degeneration
par: Yeon-Kyoung Cho, et autres
Publié: (2021)

Genetics and age-related macular degeneration: a practical review for the clinician
par: Schwartz SG, et autres
Publié: (2016)

Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration
par: Kabanarou SA, et autres
Publié: (2017)

Cone photoreceptor macular function and recovery after photostress in early non-exudative age-related macular degeneration
par: Rodriguez JD, et autres
Publié: (2018)

Physician, patient, and caregiver experience of different wet age-related macular degeneration anti-VEGF treatment regimens in Japan: a qualitative assessment
par: Iida T, et autres
Publié: (2016)

Ranibizumab in neovascular age-related macular degeneration: a 5-year follow-up
par: Cvetkova NP, et autres
Publié: (2016)

Complement Factor H Loss in RPE Cells Causes Retinal Degeneration in a Human RPE-Porcine Retinal Explant Co-Culture Model
par: Angela Armento, et autres
Publié: (2021)

Three-year results of a modified photodynamic therapy procedure (Ironing PDT) for age-related macular degeneration patients with large lesions
par: Otsuji T, et autres
Publié: (2016)

Correlation of Baseline Visual Acuity with Outcomes of Treatment with Anti-VEGF in Neovascular Age-Related Macular Degeneration
par: Veluswamy B, et autres
Publié: (2020)

The effect of intravitreal injections on dry eye, and proposed management strategies
par: Laude A, et autres
Publié: (2017)

OCT Angiography-based Evaluation of the Choriocapillaris in Neovascular Age-related Macular Degeneration
par: Varsha Pramil, et autres
Publié: (2021)

Refractive Error and Eye Health: An Umbrella Review of Meta-Analyses
par: Yin-hao Wang, et autres
Publié: (2021)

Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration
par: Koike N, et autres
Publié: (2019)

Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?
par: Dimitrios A Karagiannis, et autres
Publié: (2009)

Aqueous humor cytokine levels through microarray analysis and a sub-analysis based on optical coherence tomography in wet age-related macular degeneration patients
par: Jin-Ho Joo, et autres
Publié: (2021)

Randomised, Double-blind, Comparative Clinical Study of New Ranibizumab Biosimilar in Neovascular (Wet) Age-Related Macular Degeneration
par: Apsangikar P, et autres
Publié: (2021)

Recent developments in age-related macular degeneration: a review
par: Al-Zamil WM, et autres
Publié: (2017)

Selective retina therapy and thermal stimulation of the retina: different regenerative properties - implications for AMD therapy
par: Elisabeth Richert, et autres
Publié: (2021)

Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes
par: Razi F, et autres
Publié: (2016)

Exploring Consensus on Preventive Measures and Identification of Patients at Risk of Age-Related Macular Degeneration Using the Delphi Process
par: Alfredo García-Layana, et autres
Publié: (2021)

Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema
par: Fong AH, et autres
Publié: (2013)

Location of submacular hemorrhage as a predictor of visual outcome after intravitreal ranibizumab for age-related macular degeneration
par: Karagiannis D, et autres
Publié: (2017)

Improving Outcomes for Patients with Age-Related Macular Degeneration and Cataracts: The Importance of Including an Assessment of Activities of Daily Life (ADL)
par: Borkenstein AF, et autres
Publié: (2021)

Comparing Effectiveness of Three Different Anti-VEGF Treatment Regimens for Neovascular Age-Related Macular Degeneration: Two Years’ Real-World Clinical Outcomes
par: Horner F, et autres
Publié: (2021)

Decreased VEGF-A and sustained PEDF expression in a human retinal pigment epithelium cell line cultured under hypothermia
par: Takeyama,Masayuki, et autres
Publié: (2015)

Stem cell therapies for age-related macular degeneration: the past, present, and future
par: Dang Y, et autres
Publié: (2015)

Acquired Vitelliform Macular Degeneration: Characteristics and Challenges of Managing Subretinal Fluid
par: Joseph Juliano, et autres
Publié: (2021)

ANÁLISIS DE LA FRACCCIÓN LIPÍDICA DE LA YEMA DE HUEVOS POR AMD-HPTLC
par: Figueroa,Carolina E., et autres
Publié: (2002)

DETERMINATION OF ATRAZINE IN AQUEOUS SOIL EXTRACTS BY HIGH-PERFORMANCE THIN-LAYER CHROMATOGRAPHY
par: ESPINOZA,JEANNETTE, et autres
Publié: (2003)

Eye surgery in the elderly
par: Raczyńska D, et autres
Publié: (2016)

Lower cognitive function in patients with age-related macular degeneration: a meta-analysis
par: Zhou LX, et autres
Publié: (2016)